Annual Conference

2022-NCCN-Annual-Conference

Now Open! Call for Abstracts for the General Poster Session

NCCN welcomes original abstracts from investigators in the general oncology community. Submissions will be accepted from academic institutions, teaching and community hospitals, or industry. Participants from both NCCN and non-NCCN Member Institutions may submit abstracts.

The NCCN General Poster Session, including submission review, is overseen by the NCCN Oncology Research Program (ORP). The submission deadline is Wednesday, November 9, 2022, 11:59 pm ET. Corresponding authors can expect to receive notification via e-mail in mid-December 2022. For more details on the abstract submission process and poster specifications, please see the Poster Session FAQs.

 

Submit Abstract

Save the dates!

NCCN 2023 Annual Conference
Orlando World Center Marriott • Orlando, FL
Friday, March 31, 2023 – Sunday, April 2, 2023

NCCN 2023 Nursing Program: Advancing Oncology Nursing™
Orlando World Center Marriott • Orlando, FL
Thursday, March 30, 2023

NCCN 2024 Annual Conference
Orlando World Center Marriott • Orlando, FL
Friday, April 5, 2024 – Sunday, April 7, 2024

More than 30 recorded educational sessions from the NCCN 2022 Annual Conference are now available!

View topics below or visit education.nccn.org/ac2022 for more information.

Plenary Sessions

Best Practices in Oncology

Ampullary Adenocarcinoma

Anal Cancer

Bladder Cancer

Breast Cancer

Colorectal Cancer

Head and Neck Cancers

Hematologic Malignancies

Hepatocellular Carcinoma

Medical Generics and Genomics

Non-Small Cell Lung Cancer

Oncology Research

Pancreatic Adenocarcinoma

Prostate Cancer

Skin Cancers

Supportive Care and Survivorship

 

This activity is supported by educational grants from:

  • Abbott Molecular
  • Astellas and Seagen Inc.
  • AstraZeneca
  • BeiGene
  • Coherus BioSciences
  • Daiichi Sankyo
  • Eisai
  • Exact Sciences
  • Genentech, a member of the Roche Group
  • Genmab, US Inc.
  • Gilead Sciences, Inc. and Kite, A Gilead Company
  • GlaxoSmithKline
  • GRAIL, LLC
  • Kadmon Corporation, LLC.
  • Lantheus Medical Imaging Inc.
  • Lilly
  • Menarini-Stemline
  • Novartis
  • NOVOCURE
  • Olympus Corporation of the Americas
  • Pfizer Inc.
  • Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
  • Puma Biotechnology
  • SpringWorks
  • Taiho Oncology, Inc.

This educational activity is supported by a medical education grant from Karyopharm Therapeutics

This educational activity is supported by an independent medical education grant from Illumina, Inc.

This activity is supported by an independent educational grant from AbbVie, Bristol Myers Squibb, Incyte and Merck & Co., Inc.

This project has been made possible in part by a grant from Varian Medical Systems, a Siemens Healthineers company /Global Medical Education Grant Program

This activity has been supported by an unrestricted educational grant from GE Healthcare, Pharmaceutical Diagnostics

This activity is supported by educational funding provided by Amgen

Ruby

Pharmacyclics LLC., an AbbVie Company              


Emerald

AstraZeneca

BeiGene

Coherus BioSciences

Eisai Inc.          

Gilead & Kite Oncology 

Incyte

Janssen Oncology         

Karyopharm Therapeutics, Inc.

 

Topaz

AbbVie

Amerisource Bergen      

GSK      

Heron Therapeutics, Inc.

Lantheus           

 

Jade

Servier Pharmaceuticals


Related Program

AC2022-Nursing-Web-ads-728x90

NCCN 2022 Nursing Program: Advancing Oncology Nursing™
This program was held as a live virtual event on Wednesday, March 30, 2022.

View Recorded Presentations

 

Save the date!
NCCN 2023 Nursing Program: Advancing Oncology Nursing™
Orlando World Center Marriott • Orlando, FL
Thursday, March 30, 2023